respiratory syncytial virus

Dr Kieran Moore: RSV trends are beginning to stabilize

eAwaz Health

TORONTO — Dr Kieran Moore, Chief Medical Officer of Health, issued the following statement providing an update on the province’s progress responding to this year’s respiratory illness season: “Thanks to the ongoing resilience and commitment of Ontarians, we are seeing a decline in respiratory syncytial virus (RSV), flu and COVID activity throughout the province. RSV trends are beginning to stabilize …

Tab.Paxlovid for covid treatment

Oral antiviral Covid pill’s dispensation Paxlovid increased 

eAwaz Medicine

Ontario – Oral antiviral Covid pill’s dispensation Paxlovid increased by over 130 per cent since pharmacists were permitted to prescribe the medication to patients since Dec. 12. Prior to that a prescription from a doctor or clinical assessment centre was required to access the treatment. It works best when taken within five days of start of symptoms. Patients take two …

St. Michaels Hospital

Canada invests $10m in research on outpatient medications for Covid-19

eAwaz Medicine

Ottawa – When COVID-19 first emerged, the Government of Canada and the research community quickly stepped up to develop testing approaches, public health measures, and new vaccines to protect Canadians from the health challenges of the COVID-19 pandemic. The Government of Canada is also investing in safe and effective COVID-19 therapeutics, including antiviral medications. In response to the pressing need …

The United States has doubled its purchases of Pfizer pills to prevent Corona

Pfizer to Invest $120M to Produce Covid-19 Oral Treatment in US

eAwaz Medicine

NEW YORK- Pfizer Inc. (NYSE: PFE) announced today that it will further strengthen its commitment to United States manufacturing with a $120 million investment at its Kalamazoo, Michigan, facility, enabling U.S.-based production in support of its COVID-19 oral treatment, PAXLOVIDTM (nirmatrelvir [PF-07321332] tablets and ritonavir tablets). The investment will expand the production of active pharmaceutical ingredient (API) and registered starting materials (RSMs) …

Tab.Paxlovid for covid treatment

WHO nod for Pfizer’s Covid-19 antiviral pill 

eAwaz Medicine

Washington – The World Health Organization gave green light to use Pfizer Inc’s oral COVID-19 antiviral treatment in high-risk patients after an analysis of trial data by it showed the therapy dramatically cut the risk of hospitalization. The recommendation comes as thousands of people die of COVID-19 every week, despite a waning global infection rate. Of existing COVID-19 treatments, Pfizer’s PFE.N Paxlovid is by far …


Britain widens access to Pfizer’s Covid antiviral drug

eAwaz Medicine

Reuters – Britain will expand access to Pfizer’s oral antiviral Covid-19 treatment to thousands more people by adding it to a trial to assess how best to use the drug in its highly vaccinated population, the health ministry has said. Paxlovid, a combination of Pfizer’s new pill with an older antiviral ritonavir, was made available to thousands of people with …